We're one of the tools being compared here, so take this with appropriate skepticism — we'll try to be honest. Finviz and DilutionWatch serve fundamentally different primary use cases, and whether one is "better" for you depends entirely on what you need.
Short answer: if you want to screen stocks by fundamentals, technicals, or sector filters, Finviz is excellent. If you want to track SEC dilution risk in real time, DilutionWatch is purpose-built for that job. Many investors use both.
DilutionWatch is built specifically for tracking stock dilution from SEC filings. It polls EDGAR every 60 seconds, covers 10,000+ tickers, and scores each with a proprietary Dilution Risk Score based on shelf registration capacity, ATM activity, warrant overhang, cash runway, and dilution history. It's not a general-purpose screener — it does one thing: help you understand and track dilution risk.
Finviz is a comprehensive stock screening and visualization tool covering fundamentals, technicals, news, and insider activity. The Elite tier adds real-time data and alerts. Finviz covers thousands of stocks with rich financial data, charting tools, and sector/industry analysis. It has some SEC filing visibility but is not purpose-built for real-time dilution monitoring.
| Feature | DilutionWatch | Finviz |
|---|---|---|
| Primary purpose | SEC dilution tracking | Stock screening & charting |
| Real-time SEC alerts | Yes — 60-second EDGAR polling | Limited (news alerts, not filing-specific) |
| Dilution risk score | Yes — composite 0–100 score | No |
| Shelf registration tracking | Yes | No |
| ATM program detection | Yes | No |
| Warrant/convertible tracking | Yes | No |
| Stock screener | No | Excellent — 60+ filters |
| Technical charts | No | Yes — extensive |
| Fundamental data | Limited | Comprehensive |
| Insider trading tracking | Yes | Yes (more comprehensive) |
| News aggregation | Limited | Yes |
| Free tier | Yes (3 tickers, full alerts) | Yes (delayed data) |
| Paid tier | $19.95–$39.95/mo | $39.50/mo (Elite) |
This is where the tools diverge most sharply. Finviz aggregates news that may reference SEC filings, and the Elite tier has some filing-based alerts — but it's not built to track the specific filings that signal dilution (424B series, S-3/A amendments, 8-K SPA disclosures, DEF 14A proxy votes).
DilutionWatch monitors 25+ filing types specifically curated for dilution risk, with each filing parsed for its dilution implications and scored accordingly. A 424B5 prospectus supplement on an existing shelf triggers an immediate alert and score update.
Finviz has no equivalent to DilutionWatch's Dilution Risk Score. You can use Finviz fundamentals (short float %, institutional ownership, etc.) to infer some dilution risk indicators, but there's no composite score that synthesizes shelf capacity + ATM activity + warrant overhang + cash runway into a single actionable number.
DilutionWatch's DilutionScore™ is purpose-built to answer the question: "How likely is this company to dilute shareholders in the near term?" That's not a question Finviz was designed to answer.
Both tools have meaningful free tiers. Finviz's free tier has delayed data and limited features. DilutionWatch's free tier covers 3 tickers with full real-time alerts and risk scoring — adequate for investors tracking their highest-conviction positions.
Finviz Elite ($39.50/month) adds real-time data, custom screeners, and advanced alerts. DilutionWatch Basic ($19.95/month) adds 15 tracked tickers, email alerts, and expanded filing history. The right choice depends on your workflow.
Use Finviz to find stocks and understand their fundamentals. Use DilutionWatch to monitor those stocks for active dilution risk. The two tools are complementary, not competitive — most dilution-aware investors benefit from both.
When it comes to tracking dilution, investors need tools that go beyond basic stock screening. While Finviz is a powerful platform for general market research, it lacks the depth and specificity needed to monitor dilution risks effectively. In contrast, DilutionWatch has been built from the ground up to help investors understand how capital structure changes impact their portfolios.
DilutionWatch excels in specific investor use cases that Finviz simply cannot cover:
DilutionWatch pulls real-time data directly from SEC EDGAR filings and updates its database multiple times daily, ensuring investors get the most current dilution information available. Finviz, while using SEC data sources, does not update as frequently and often lags in incorporating new filing details. DilutionWatch’s focus on and Weekly Dilution Report further enhances its ability to surface emerging risks.
| Feature | DilutionWatch | Finviz |
|---|---|---|
| Basic Screening | Free tier available with limited filters | Free + paid tiers |
| Dilution Tracking | Advanced, real-time tracking | No native dilution metrics |
| Alerts & Monitoring | Premium features with email alerts | Limited monitoring tools |
For retail investors tracking 5–20 positions, DilutionWatch’s premium tier offers excellent value for those actively seeking to monitor dilution risks. Finviz may be sufficient for general research but falls short when it comes to actionable insights on share issuance and dilution impact.
If you're a retail or institutional investor focused on identifying and monitoring dilution risks, DilutionWatch is the superior choice. It provides tools like the DilutionWatch, , and Shelf & ATM Monitor that Finviz simply does not offer. For those looking for a general stock research platform, Finviz remains a solid tool—but not for dilution-specific tracking.
Recommendation: Use Finviz for general market and company research. Switch to DilutionWatch when you want real-time insight into dilution events, warrant issuance, or PIPE deals affecting your portfolio.
DilutionWatch's free tier gives you real-time SEC alerts and DilutionScore™ for 3 tickers. No credit card required.
Start Free →